-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Theravance Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2018 to Q3 2024.
- Theravance Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 49M shares, a 6.35% decline year-over-year.
- Theravance Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 55.3M shares, a 24.9% decline from 2022.
- Theravance Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 73.6M shares, a 5.95% increase from 2021.
- Theravance Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 69.5M shares, a 11.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)